News

Last Energy plans to source at least 10% of its supply chain for the project in South Wales, generating an estimated £30m ...
Plans for a pioneering small modular reactor nuclear power plant in the Llynfi Valley have been boosted with completion of a preliminary design review (PDR) with UK regulators.
In the QSR and fast-casual world, uniformity is treated like a commandment. Sameness is seen as safety, especially when it ...
Southwest Airlines is buckling up to join in on a long-running legal battle surrounding an alleged price-fixing scheme involving generic medicines in the U.S.
Find out PCB design strategies to reduce EMI in 800G systems while maintaining high performance in data center and telecom ...
It said the price for generic semaglutide is expected to be available at a significant discount to the branded versions, with the prices expected to lower over time. Hims and Hers stock traded up as ...
Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to invalidate a patent covering its schizophrenia medication Invega Sustenna.
Hartlepool nuclear power station operator EDF has been given extra time to carry out improvements after receiving the notice from the Office for Nuclear Regulation (ONR) in May.
Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug Entresto before its patent expires late next year, a Delaware federal ...
US judge denies Novartis' injunction request against MSN Pharmaceuticals selling generic Entresto, citing public interest and lack of harm.
Hims & Hers Health is planning an entry into the Canadian market next year, timing it with the new availability of a generic weight loss drug a month after losing rights to sell Novo Nordisk's ...